Webinars and Sponsored Roundtables — Register Now

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.

Webinar presenter Jeffrey Gregg, MD, University of Nevada

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

Marketplace Directory

Posters on POC assays, 10/16

October 2016—ET Healthcare presented two posters at the meeting. Data from the abstract “A whole blood high-sensitivity cardiac troponin assay for POCT” showed that the Pylon cTnl assay met the definition of a fourth-generation high-sensitivity cardiac troponin I assay, with less than 10 percent CV at the 99th percentile and detection in greater than 95 percent of the reference population.

eLearning interface, 10/16

October 2016—Telcor’s QML eLearning interface performs tasks vital to managing point-of-care-testing operators while storing recertification data, such as competency and samples performed together in the company’s QML software for CAP/CMS/JCAHO inspections.

Mass spectrometry medical devices, 10/16

October 2016—Waters Corp. showcased its newest IVD medical device for clinical laboratories, the Acquity UPLC I-Class/Xevo TQ-S micro IVD system. The Xevo TQ-XS is a high-performance tandem quadrupole instrument that aims to expand the scope of ultimate sensitivity analysis.

High-volume platforms, inventory solutions, 10/16

October 2016—Roche launched its presence by featuring several next-generation diagnostic testing platforms and a virtual reality experience that was designed to give attendees an “under the hood” look at a lab of the future and a concept Roche calls the “Roche connected lab.”

Transfusion medicine instrument, predictive technology, 10/16

October 2016—Products on display in Ortho Clinical’s booth included the company’s flagship Integrated Clinical Chemistry and Immunodiagnostic Systems and the Nephrocheck Test. The Ortho Vision Max transfusion medicine instrument (shown below), which is pending 510(k) clearance, was highlighted as well.

Bulk sorter configuration for frozen specimens, 10/16

October 2016—Yaskawa Motoman’s AutoSorter 2000BB bulk sorter has a new configuration available that can maintain frozen specimens in a -20°C environment during the sorting process. The high-speed bulk sorter for high-volume commercial laboratories provides maximum specimen throughput at up to 2,000 tubes per hour.

Ultraprotective vials, 10/16

October 2016—Wheaton launched its DualFusion Vial, which combines properties of plastic and glass into one container. Using plasma enhanced chemical vapor deposition (PECVD) technology, an organosilicate protective layer is fused with a silica-like (SiO2 barrier) layer that is fused to a cyclic olefin polymer (COP) shell to form a robust, covalently bonded material.

Tests for M. genitalium, 10/16

October 2016—SpeeDx Pty, Ltd., featured its PlexPCR for the detection of infectious disease pathogens and the ResistancePlus multiplex qPCR test for the detection of Mycoplasma genitalium and antimicrobial resistance markers.

Streck signs distribution agreement, 10/16

October 2016—Streck and Diesse Diagnostica Senese S.p.A., an Italian manufacturer of in vitro diagnostic systems, are introducing the Diesse Mini-Cube, an automated instrument for erythrocyte sedimentation rate testing in EDTA tubes. Streck will be the exclusive distributor of the Mini-Cube in the United States and Canada.